Carlsmed
Carlsbad
About Carlsmed
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbar fusion surgery. Carlsmed was founded in 2018 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $109.0M
- Funding stage: IPO
- Last round: Series C (Mar 2024)
- Ticker: nasdaq:CARL
- Website: carlsmed.com
- Phone: +1 858-295-9290
Industries & Categories
Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/carlsmed-114227 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.